Category archive
Browse every WeightEasy article in the GLP-1 Basics category.
Category pages gather broader article themes, which makes them useful for readers who are exploring a whole area like injection routines, side effects, or dose tracking rather than a single narrow question.
For years, Indian patients who needed semaglutide had limited options. Ozempic was available as an expensive import, often costing ₹10,000 to ₹18,000 per month well beyond the reac...
When Obeda launched in India in March 2026, it sparked a lot of questions. Is it a diabetes drug? A weight loss drug? Or both? The short answer is: both. But the how it is used, wh...
If your doctor recently mentioned Obeda, or you have been seeing it pop up in health news, you are not alone. Since India's semaglutide patent expired on March 20, 2026, Obeda has...
Obeda has made headlines since its launch in India and rightly so. But that excitement can lead some people to assume it is for everyone who wants to lose weight. It is not. Obeda...